MichaelSchreiberMD

Neonat/Perinatology • Chicago, IL

Neonatal Neurodevelopment, Neonatal Respiratory Failure & Lung Development

Professor and Section Chief

Join to view full profile

Dr. Schreiber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Schreiber's full profile

Already have an account?

Office
5841 S. MARYLAND AVE.
M/C 6060
Chicago, IL 60637
Phone+1 773-702-6205

Fax+1 773-702-4523
Is this information wrong?

Education & Training

McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 1979 - 1982
Rush Medical College of Rush University Medical CenterClass of 1979

Certifications & Licensure

CA State Medical License 1982 - Present
IL State Medical License 1981 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Neonatal-Perinatal Medicine

Clinical Trials

Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants. Start of enrollment: 2006 Dec 01
Terminated
Phase 4
Oropharyngeal Administration of Mother's Colostrum for Premature Infants (NS-72393-360) Start of enrollment: 2013 Nov 20
Completed
Not Applicable

Publications & Presentations

PubMed

52 citations
Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.
Yvonne W Wu, Bryan A Comstock, Fernando F Gonzalez, Dennis E Mayock, Amy M Goodman, Nathalie L Maitre, Taeun Chang, Krisa P Van Meurs, Andrea L Lampland, Ellen Bendel-...> ;The New England Journal of Medicine. 2022 Jul 14
1 citations
Implementation of an Inhaled Nitric Oxide Weaning Protocol and Stewardship in a Level 4 NICU to Decrease Inappropriate Use.
Walid A Hussain, Deborah S Bondi, Sherwin E Morgan, Sudhir Sriram, Michael D Schreiber, Shah, P.> ;The Journal of Pediatric Pharmacology and Therapeutics. 2022 Jan 1
A High-Fidelity Model to Predict Length-of-Stay in the Neonatal Intensive Care Unit (NICU).
Kanix Wang, Walid Hussain, John R Birge, Michael D Schreiber, Daniel Adelman> ;INFORMS Journal on Computing. 2021 Aug 30
The Test of Infant Motor Performance at 3 months predicts language, cognitive, and motor outcomes in infants born preterm at 2 years of age.
Peyton, C.,Schreiber, M. D.,Msall, M. E.> ;Dev Med Child Neurol. 2018 Mar 14
Efficacy of inhaled nitric oxide in neonates with hypoxic respiratory failure and pulmonary hypertension: the Japanese experience.
Suzuki, S.,Togari, H.,Potenziano, J. L.,Schreiber, M. D.> ;J Perinat Med. 2017 Sep 20
Reply.
Ballard, R. A.,Ballard, P. L.,Askie, L. M.,Schreiber, M. D.,Hibbs, A. M.,Torgerson, D. G.,Keller, R. L.> ;J. Pediatr.. 2018 Jul 22
The nonimpact of gestational age on neurodevelopmental outcome for ventilated survivors born at 23-28 weeks of gestation.
Andrews, B., Lagatta, J., Chu, A., Plesha-Troyke, S., Schreiber, M., Lantos, J., Meadow, W.> ;Acta Paediatr. 2012 Jun
Inhaled nitric oxide in premature infants with the respiratory distress syndrome.
Schreiber, M. D.,Gin-Mestan, K.,Marks, J. D.,Huo, D.,Lee, G.,Srisuparp, P.> ;N. Engl. J. Med.. 2003 Dec 04
Join now to see all

Hospital Affiliations

University of Chicago Medical CenterChicago, Illinois
OSF Healthcare Little Company of Mary Medical CenterEvergreen Park, Illinois
Comer Childrens HospitalChicago, Illinois
Comer Childrens HospitalChicago, Illinois